See more : Kanda Tsushinki Co., Ltd. (1992.T) Income Statement Analysis – Financial Results
Complete financial analysis of Granules India Limited (GRANULES.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Granules India Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Indian Railway Finance Corporation Limited (IRFC.NS) Income Statement Analysis – Financial Results
- Onesource Ideas Venture Limited (OIVL.BO) Income Statement Analysis – Financial Results
- WISeKey International Holding AG (WKEY) Income Statement Analysis – Financial Results
- EQ Resources Limited (EQR.AX) Income Statement Analysis – Financial Results
- CHN Energy Changyuan Electric Power Co., Ltd. (000966.SZ) Income Statement Analysis – Financial Results
Granules India Limited (GRANULES.NS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.granulesindia.com
About Granules India Limited
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other specialty products for oncology. The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 45.06B | 45.12B | 37.27B | 31.96B | 25.45B | 22.34B | 16.35B | 14.10B | 14.30B | 12.93B | 10.96B | 7.64B | 6.54B | 4.75B | 4.61B | 0.00 | 2.56B | 1.88B |
| Cost of Revenue | 21.31B | 23.07B | 19.59B | 14.55B | 13.16B | 12.85B | 9.25B | 7.03B | 8.61B | 8.36B | 7.12B | 4.74B | 4.14B | 3.89B | 3.71B | 0.00 | 2.04B | 1.48B |
| Gross Profit | 23.76B | 22.05B | 17.68B | 17.41B | 12.30B | 9.49B | 7.09B | 7.07B | 5.69B | 4.57B | 3.84B | 2.90B | 2.40B | 856.84M | 896.82M | 0.00 | 520.14M | 400.51M |
| Gross Profit Ratio | 52.72% | 48.86% | 47.44% | 54.47% | 48.31% | 42.48% | 43.40% | 50.16% | 39.79% | 35.36% | 35.00% | 37.98% | 36.64% | 18.03% | 19.45% | 0.00% | 20.28% | 21.29% |
| Research & Development | 1.99B | 1.16B | 1.43B | 1.00B | 789.09M | 725.14M | 524.78M | 256.75M | 165.40M | 96.10M | 67.92M | 54.61M | 0.00 | 34.09M | 36.71M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 851.26M | 738.75M | 514.43M | 375.62M | 339.81M | 286.15M | 265.03M | 167.36M | 159.98M | 182.44M | 103.92M | 83.80M | 0.00 | 254.59M | 239.46M | 0.00 | 155.51M | 106.20M |
| Selling & Marketing | 2.91B | 2.80B | 2.47B | 1.60B | 1.12B | 918.35M | 830.78M | 813.73M | 703.46M | 697.25M | 730.45M | 585.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.76B | 3.54B | 2.99B | 1.97B | 1.46B | 1.20B | 1.10B | 981.08M | 863.44M | 879.69M | 834.36M | 669.10M | 0.00 | 254.59M | 239.46M | 0.00 | 155.51M | 106.20M |
| Other Expenses | 17.90B | 10.05B | 7.52B | 7.28B | 5.80B | 61.62M | 10.69M | 47.54M | 4.44M | 2.89B | 2.45B | 2.35B | 1.81B | 180.69M | 181.30M | 0.00 | 108.32M | 63.05M |
| Operating Expenses | 23.64B | 14.75B | 11.93B | 10.25B | 8.05B | 6.70B | 5.06B | 4.74B | 3.51B | 2.98B | 2.53B | 2.26B | 1.81B | 469.38M | 457.47M | 0.00 | 263.83M | 169.25M |
| Cost & Expenses | 38.90B | 37.83B | 31.52B | 24.80B | 21.21B | 19.55B | 14.31B | 11.77B | 12.11B | 11.34B | 9.66B | 7.00B | 5.95B | 4.36B | 4.17B | 0.00 | 2.31B | 1.65B |
| Interest Income | 27.97M | 45.14M | 128.54M | 123.79M | 63.62M | 72.63M | 30.68M | 44.13M | 51.89M | 14.55M | 11.75M | 8.04M | 6.28M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.06B | 559.33M | 118.39M | 196.18M | 216.62M | 227.37M | 260.54M | 271.88M | 335.82M | 279.71M | 147.12M | 128.16M | 160.90M | 125.87M | 175.49M | 0.00 | 130.29M | 121.63M |
| Depreciation & Amortization | 2.07B | 1.84B | 1.59B | 1.51B | 1.37B | 1.05B | 762.02M | 715.13M | 643.30M | 526.51M | 298.13M | 230.85M | 206.95M | 183.15M | 185.74M | 0.00 | 116.57M | 82.09M |
| EBITDA | 8.26B | 9.28B | 7.40B | 8.82B | 5.90B | 4.11B | 2.89B | 3.09B | 2.82B | 2.13B | 1.57B | 822.25M | 804.91M | 576.57M | 737.20M | 0.00 | 372.89M | 313.35M |
| EBITDA Ratio | 18.34% | 20.56% | 19.67% | 27.50% | 24.29% | 20.33% | 18.31% | 21.49% | 19.72% | 16.15% | 14.22% | 10.99% | 12.31% | 12.13% | 15.99% | 0.00% | 14.54% | 16.66% |
| Operating Income | 6.53B | 7.82B | 5.75B | 7.28B | 4.81B | 2.79B | 2.03B | 2.38B | 2.18B | 1.59B | 1.31B | 628.14M | 590.66M | 387.46M | 439.34M | 0.00 | 256.31M | 231.26M |
| Operating Income Ratio | 14.49% | 17.33% | 15.42% | 22.76% | 18.91% | 12.49% | 12.44% | 16.86% | 15.24% | 12.29% | 11.99% | 8.22% | 9.03% | 8.15% | 9.53% | 0.00% | 9.99% | 12.29% |
| Total Other Income/Expenses | -1.06B | -504.70M | -168.96M | -232.02M | -301.84M | 465.31M | -73.00M | -31.84M | -369.23M | -293.17M | -179.25M | -171.71M | -160.90M | -119.91M | -63.38M | 0.00 | -130.29M | -121.63M |
| Income Before Tax | 5.47B | 6.87B | 5.58B | 7.04B | 4.51B | 3.26B | 1.96B | 2.05B | 1.80B | 1.28B | 1.12B | 463.25M | 429.77M | 267.55M | 375.96M | 0.00 | 126.02M | 109.63M |
| Income Before Tax Ratio | 12.14% | 15.23% | 14.97% | 22.04% | 17.72% | 14.57% | 11.99% | 14.54% | 12.60% | 9.90% | 10.25% | 6.06% | 6.57% | 5.63% | 8.15% | 0.00% | 4.91% | 5.83% |
| Income Tax Expense | 1.42B | 1.71B | 1.45B | 1.55B | 1.16B | 891.11M | 633.99M | 652.01M | 616.78M | 370.53M | 371.30M | 137.57M | 130.24M | 58.60M | 72.24M | 0.00 | 35.98M | 33.67M |
| Net Income | 4.05B | 5.17B | 4.13B | 5.49B | 3.35B | 2.36B | 1.33B | 1.65B | 1.18B | 909.08M | 752.31M | 325.67M | 299.53M | 208.96M | 303.72M | 0.00 | 90.04M | 75.96M |
| Net Income Ratio | 8.99% | 11.45% | 11.07% | 17.19% | 13.18% | 10.58% | 8.11% | 11.67% | 8.29% | 7.03% | 6.87% | 4.26% | 4.58% | 4.40% | 6.59% | 0.00% | 3.51% | 4.04% |
| EPS | 16.73 | 21.05 | 16.65 | 22.05 | 13.19 | 9.30 | 5.49 | 7.52 | 5.95 | 4.46 | 3.72 | 1.62 | 1.49 | 1.04 | 1.51 | 0.00 | 0.42 | 0.51 |
| EPS Diluted | 16.72 | 21.02 | 16.60 | 21.95 | 13.15 | 9.28 | 5.47 | 7.48 | 5.83 | 4.41 | 3.65 | 1.58 | 1.49 | 1.04 | 1.51 | 0.00 | 0.42 | 0.51 |
| Weighted Avg Shares Out | 242.27M | 245.41M | 247.84M | 249.20M | 254.25M | 254.11M | 241.62M | 218.82M | 206.70M | 203.84M | 202.24M | 200.90M | 200.62M | 200.57M | 200.57M | 254.25M | 216.48M | 148.55M |
| Weighted Avg Shares Out (Dil) | 242.35M | 245.74M | 248.61M | 250.28M | 255.09M | 254.87M | 242.28M | 219.95M | 210.88M | 206.06M | 206.14M | 206.38M | 201.43M | 201.50M | 201.41M | 254.25M | 216.48M | 148.55M |
Source: https://incomestatements.info
Category: Stock Reports